CHAPTER 11
|
Juvenile Idiopathic Arthritis
365
osteoporosis, joint space narrowing, erosions, subluxation,
and ankylosis.
•
Screening flexion and extension films are recommended
prior to anesthesia if cervical disease is suspected.
•
ANA positivity is a marker of risk for JIA-associated uveitis.
•
All children with JIA should be evaluated for uveitis at diag-
nosis and routinely thereafter.
•
JIA patients are at risk for growth failure, osteoporosis, and
LLD.
REFERENCES
1. Kunnamo I, Kallio P, Pelkonen P. Incidence of arthritis in urban Finnish
children: a prospective study.
Arthritis Rheum
1986;29:2132.
2. Goodman J, McGraft P. The epidemiology of pain in children and adoles-
cents: a review.
Pain
1991;46:247.
3. McGrath P, McAlpine L. Psychologic perspectives on pediatric pain.
J Pediatr
1993;122:52.
4. Cuesta I, Kerr K, Simpson P. Subspecialty referrals for pauciarticular juve-
nile rheumatoid arthritis.
Arch Pediatr Adolesc Med
2000;154(2):122.
5. Brewer E, Bass J, Cassidy J. Criteria for the classification of juvenile rheu-
matoid arthritis.
Bull Rheum Dis
1972;23:712–719.
6. Bulletin 4.
Nomenclature and classification of arthritis in children
. Basel,
Switzerland: National Zeitung AG, 1977.
7. Fink C. Proposal for the development of classification criteria for idio-
pathic arthritides of childhood.
J Rheumatol
1995;22:1566.
8. Petty RE, et al. International League of Associations for Rheumatology
classification of juvenile idiopathic arthritis: second revision, Edmonton,
2001.
J Rheumatol
2004;31(2):390–392.
9. Foeldvari I, Bidde M. Validation of the proposed ILAR classification cri-
teria for juvenile idiopathic arthritis. International League of Associations
for Rheumatology.
J Rheumatol
2000;27(4):1069.
10. Ramsey S, Bolaria R, Cabral D. Comparison of criteria for the classifica-
tion of childhood arthritis.
J Rheumatol
2000;27(5):1283.
11. Hofer M, Mouy R, Prieur A. Juvenile idiopathic arthritides evaluated pro-
spectively in a single center according to the Durban criteria.
J Rheumatol
2001;28(5):1083.
12. Krumrey-Langkammerer M, Hafner R. Evaluation of the ILAR criteria
for juvenile idiopathic arthritis.
J Rheumatol
2001;28(11):2544.
13. Danner S, et al. Epidemiology of juvenile idiopathic arthritis in Alsace,
France.
J Rheumatol
2006;33(7):1377–1381.
14. Prahalad S. Genetics of juvenile idiopathic arthritis: an update.
Curr Opin
Rheumatol
2004;16(5):588–594.
15. Woo P, Laxer R, Sherry D.
Pediatric rheumatology in clinical practice
.
London, UK: Springer, 2007.
16. Morling N, et al. DNA polymorphism of HLA class II genes in pau-
ciarticular juvenile rheumatoid arthritis.
Tissue Antigens
1991;38(1):
16–23.
17. Sherry DD, et al. Painless juvenile rheumatoid arthritis.
J Pediatr
1990;116(6):921–923.
18. Bunger C, Bulow J, Tondebold E. Microcirculation of the juvenile knee
in chronic arthritis.
Clin Orthop
1986;204:294.
19. Vostrejs M, Hollister J. Muscle atrophy and leg length discrepancies
in pauciarticular juvenile rheumatoid arthritis.
Am J Dis Child
1988;
142:343.
20. Weiss PF, et al. High prevalence of temporomandibular joint arthritis at
disease onset in children with juvenile idiopathic arthritis, as detected
by magnetic resonance imaging but not by ultrasound.
Arthritis Rheum
2008;58(4):1189–1196.
21. Twilt, M, et al. Temporomandibular involvement in juvenile idiopathic
arthritis.
J Rheumatol
2004;31(7):1418–1422.
22. Bakke M, et al. Orofacial pain, jaw function, and temporomandibular dis-
orders in women with a history of juvenile chronic arthritis or persistent
juvenile chronic arthritis.
Oral Surg Oral Med Oral Pathol Oral Radiol
Endod
2001;92(4):406–414.
23. Karhulahti T, Ronning O, Jamsa T. Mandibular condyle lesions, jaw
movements, and occlusal status in 15-year-old children with juvenile
rheumatoid arthritis.
Scand J Dent Res
1990;98(1):17–26.
24. Wallace CA, et al. Patterns of clinical remission in select categories of
juvenile idiopathic arthritis.
Arthritis Rheum
2005;52(11):3554–3562.
25. Symmons D, Jones M, Osborne J. Pediatric rheumatology in the United
Kingdom: data from the British Pediatric Rheumatology Group National
Diagnostic Register.
J Rheumatol
1996;23:1975.
26. Cassidy J, Levinson J, Bass J. A study of classification criteria for a diag-
nosis of juvenile rheumatoid arthritis.
Arthritis Rheum
1986;29:274.
27. Kanski J. Uveitis in juvenile chronic arthritis.
Eye
1988;2:641.
28. Blane C, Ragsdale C, Hensinger R. Late effects of JRA on the hip.
J Pediatr Orthop
1987;7:677.
29. Schneider R, Laxer R. Systemic onset juvenile rheumatoid arthritis.
Baillieres Clin Rheum
1998;12:245.
30. De Benedetti F, et al. Functional and prognostic relevance of the
–173 polymorphism of the macrophage migration inhibitory factor
gene in systemic-onset juvenile idiopathic arthritis.
Arthritis Rheum
2003;48(5):1398–1407.
31. Calabro J, Marchesano J. Fever associated with juvenile rheumatoid
arthritis.
N Engl J Med
1967;276:11.
32. Calabro J, Marchesano J. Rash associated with juvenile rheumatoid
arthritis.
J Pediatr
1968;72:611.
33. Behrens EM, et al. Evaluation of the presentation of systemic onset juve-
nile rheumatoid arthritis: data from the Pennsylvania Systemic Onset
Juvenile Arthritis Registry (PASOJAR).
J Rheumatol
2008;35(2):343–348.
34. Schneider R, Lang B, Reilly B. Prognostic indicators of joint destruction
in systemic-onset juvenile rheumatoid arthritis.
J Pediatr
1992;120:200.
35. David J, Vouyiouka O, Ansell B. Amyloidosis in juvenile chronic arthritis:
a morbidity and mortality study.
Clin Exp Rheumatol
1993;11:85.
36. Prieur A, Stephan J. Macrophage activation syndrome in children with
joint diseases.
Rev Rheum Engl Ed
1994;61:385.
37. Ravelli A, Benedetti FD, Viola S. Macrophage activation syndrome in sys-
temic juvenile rheumatoid arthritis successfully treated with cyclosporine.
J Pediatr
1996;128:275.
38. Mouy R, Stephan J, Pillet P. Efficacy of cyclosporine A in the treatment of
macrophage activation syndrome in juvenile arthritis: report of five cases.
J Pediatr
1996;129:750.
39. Pascual V, et al. Role of interleukin-1 (IL-1) in the pathogenesis of sys-
temic onset juvenile idiopathic arthritis and clinical response to IL-1
blockade.
J Exp Med
2005;201(9):1479–1486.
40. Church R. The prospect of psoriasis.
Br J Dermatol
1958;70(4):139–145.
41. Baker H. Epidemiological aspects of psoriasis and arthritis.
Br J Dermatol
1966;78(5):249–261.
42. Green L, et al. Arthritis in psoriasis.
Ann Rheum Dis
1981;40(4):
366–369.
43. Ho PY, et al. HLA-Cw6 and HLA-DRB1*07 together are associ-
ated with less severe joint disease in psoriatic arthritis.
Ann Rheum Dis
2007;66(6):807–811.
44. Southwood T, Petty R, Malleson P. Psoriatic arthritis in children.
Arthritis
Rheum
1989;32:1007.
45. Roberton D, Cabral D, Malleson P. Juvenile psoriatic arthritis: follow-up
and evaluation of diagnostic criteria.
J Rheumatol
1996;23:166.
46. Petty R, Southwood T, Baum J. Revision of the proposed classification
criteria for juvenile idiopathic arthritis: Durban, 1997.
J Rheumatol
1998;25:1991.
47. Shore A, Ansell B. Juvenile psoriatic arthritis: an analysis of 60 cases.
J Pediatr
1982;100:529.
48. Wesolowska H. Clinical course of psoriatic arthropathy in children.
Mater
Med Pol
1985;55:185.
49. Rosenberg A, Petty R. A syndrome of seronegative enthesopathy and
arthropathy in children.
Arthritis Rheum
1982;25:1041.
50. Cabral D, Oen K, Petty R. SEA syndrome revisited: a long-term followup
of children with a syndrome of seronegative enthesopathy and arthropa-
thy.
J Rheumatol
1992;19:1282.
